Cargando…

Biomarker development in MET-targeted therapy

Activation of the MET receptor tyrosine kinase by its ligand, hepatocyte growth factor (HGF), has been implicated in a variety of cellular processes, including cell proliferation, survival, migration, motility and invasion, all of which may be enhanced in human cancers. Aberrantly activated MET/HGF...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yanni, Du, Zhiqiang, Zhang, Mingqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5095083/
https://www.ncbi.nlm.nih.gov/pubmed/27013592
http://dx.doi.org/10.18632/oncotarget.8276